2

Management of beta thalasseamia major

Year:
1994
Language:
english
File:
PDF, 642 KB
english, 1994
12

Combined therapy with deferiprone and desferrioxamine

Year:
1998
Language:
english
File:
PDF, 240 KB
english, 1998
13

BONE DISEASE IN β-THALASSAEMIA MAJOR

Year:
1998
Language:
english
File:
PDF, 109 KB
english, 1998
14

High prevalence of low bone mass in thalassaemia major

Year:
1998
Language:
english
File:
PDF, 100 KB
english, 1998
23

Equal-time commutators with improved energy-momentum tensor

Year:
1972
Language:
english
File:
PDF, 318 KB
english, 1972
24

4 The management of haemoglobinopathies

Year:
1991
Language:
english
File:
PDF, 3.55 MB
english, 1991
25

5 Results of long-term subcutaneous desferrioxamine therapy

Year:
1989
Language:
english
File:
PDF, 1.76 MB
english, 1989
27

Clinical aspects of transfusional iron overload

Year:
2000
Language:
english
File:
PDF, 909 KB
english, 2000
31

SECONDARY ERYTHROCYTOSIS AND SARCOIDOSIS

Year:
1989
Language:
english
File:
PDF, 220 KB
english, 1989
40

Sperm concentrations and quality in β-thalassaemia major

Year:
1996
Language:
english
File:
PDF, 209 KB
english, 1996
41

Deferiprone-associated myelotoxicity

Year:
1994
Language:
english
File:
PDF, 356 KB
english, 1994
44

Management of pregnancy in a patient with β thalassaemia major

Year:
2005
Language:
english
File:
PDF, 81 KB
english, 2005
45

Clinical management of β-Thalassemia major

Year:
2001
Language:
english
File:
PDF, 1.24 MB
english, 2001
47

Impact and future of screening for haemoglobin disorders

Year:
1998
Language:
english
File:
PDF, 656 KB
english, 1998
48

Arthropathy in thalassaemia patients receiving deferiprone

Year:
1994
Language:
english
File:
PDF, 330 KB
english, 1994